menu

Podcasts

PBC | Podcasts

cardImg

Importance of Understanding Impact on Disease Outcomes: Progression to Fibrosis and Cirrhosis
cardImg

PBC vs. PSC – Spotting the Differences

Christopher Bowlus MD , Kris Kowdley MD

cardImg

Alcoholic Liver Disease – A Growing Epidemic

Steven Flamm MD , Mack Mitchell MD

cardImg

Building a Sense of Urgency for PBC Patient Evaluation/Monitoring
cardImg

Need for Earlier Evaluation of UDCA Response, Need for Earlier Consideration of Second-Line Therapy
cardImg

Not Responding to UDCA in the First Few Months, Need to Move on to Second-Line Therapy
cardImg

Biomarkers Beyond ALP to Monitor for Measuring PBC UDCA Response to Therapy and Disease Progression
cardImg

Better Understanding of PBC Patients Overall Liver Health and Managing Patients Holistically
cardImg

Unable to Differentiate/Identify Between Slow & Fast Progressors - Need to Manage More Aggressively
cardImg

Need for Clinicians to Better Understand The "Area Under the Curve" in Non-Response to UDCA